Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/1507
Full metadata record
DC FieldValueLanguage
dc.contributor.authorREGNO:BG0120004-
dc.date.accessioned2023-10-18T06:27:38Z-
dc.date.available2023-10-18T06:27:38Z-
dc.date.issued2023-10-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/1507-
dc.description.abstractBACKGROUND: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with significant morbidity and mortality. The aim of the present stusy was to evaluate the role of HNC-LL score as an early predictor of COVID-19 severity and to further compare its effectiveness with known scores such as CURB-65, MuLBSTA, Neutrophil to Lymphocyte ratio.en_US
dc.language.isoen_USen_US
dc.publisherKLE Academy of Higher Education and Research, Belagavien_US
dc.subjectCOVID-19, HNC-LL, screening, early diagnosis disease severity, outcomeen_US
dc.title“To study hnc-ll as a potential score For predicting severity in covid-19 Patients - a one year hospital based Cross sectional study in kles Dr.prabhakar kore hospital and medical Research centre, belagavi.”en_US
dc.typeDissertationsen_US
Appears in Collections:General Medicine MD

Files in This Item:
File Description SizeFormat 
BG0120004.pdf3.91 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.